MG
LHDX

Michael Gelband’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Michael Gelband’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,300
Closed -$97K – 2819
2021
Q4 		$97K Buy
+11,300
New +$71.9K ﹤0.01% 1957

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Michael Gelband's LHDX Position: Q1 2022 in Review

Michael Gelband sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 11,300 shares — an estimated $97K sold.

Michael Gelband first reported a position in LHDX in Q4 2021 and held it in 1 quarter. The position peaked at $97K in Q4 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

  • Michael Gelband reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Michael Gelband sold 11,300 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $97K.
  • Michael Gelband first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Michael Gelband's Lucira Health, Inc. Common Stock position peaked at $97K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.